Discover how the breakthrough pill orforglipron matches injectable weight loss drugs in effectiveness while offering ...

Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

It won't come as a surprise to anyone to hear that quite a few quality stocks have performed terribly this year. Some have ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.

Pharmaceutical company Ely Lilly dubbed it orforglipron. “Or-“ is for oral administration (no shots!), and the other syllables pertain to the way it works, ending with a common suffix for drug names.

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last month.

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...